These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4916023

  • 1. Vincristine therapy of lymphomas and chronic lymphocytic leukemia.
    Desal DV, Ezdinli EZ, Stutzman L.
    Cancer; 1970 Aug; 26(2):352-9. PubMed ID: 4916023
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
    Cajozzo A, Citarrella P, Carreca I, D'Eredità F.
    Haematologica; 1970 Aug; 55(7):465-70. PubMed ID: 4996520
    [No Abstract] [Full Text] [Related]

  • 3. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G, Schneider M, Schwarzenberg L, Cattan A, Amiel JL, Schlumberger JR.
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract] [Full Text] [Related]

  • 4. Vincristine neuropathy. Clinical and electrophysiological observations.
    Casey EB, Jellife AM, Le Quesne PM, Millett YL.
    Brain; 1973 Jan; 96(1):69-86. PubMed ID: 4348690
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical and physiopathological effects of Vincristine on the nervous system].
    Freund HJ, Kendel K, Obrecht P.
    Dtsch Z Nervenheilkd; 1969 Oct; 196(4):319-30. PubMed ID: 4899921
    [No Abstract] [Full Text] [Related]

  • 6. Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia.
    Ezdinli EZ, Stutzman L, Aungst CW, Firat D.
    Cancer; 1969 Apr; 23(4):900-9. PubMed ID: 4887296
    [No Abstract] [Full Text] [Related]

  • 7. [Methylhydrazine in the therapy of malignant lymphopathies].
    Beltrametti L, Almici C.
    Policlinico Prat; 1967 Jan 16; 74(3):82-5. PubMed ID: 4878309
    [No Abstract] [Full Text] [Related]

  • 8. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.
    Marmont AM, Damasio EE.
    Blood; 1967 Jan 16; 29(1):1-21. PubMed ID: 5334796
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of malignant lymphomas with bleomycin.
    Kimura I, Onoshi T, Kunimasa I, Takano J.
    Cancer; 1972 Jan 16; 29(1):58-60. PubMed ID: 4109085
    [No Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy of lymphomas other than Hodgkin's disease.
    Stein RS, Moran EM, Desser RK, Miller JB, Golomb HM, Ultmann JE.
    Ann Intern Med; 1974 Nov 16; 81(5):601-8. PubMed ID: 4608355
    [No Abstract] [Full Text] [Related]

  • 11. Chemotherapy of the lymphomas.
    Lacher MJ.
    Med Times; 1970 May 16; 98(5):96-102. PubMed ID: 4911076
    [No Abstract] [Full Text] [Related]

  • 12. A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients.
    Rossof AH, Kerr RO, Braine HG, Coltman CA.
    Med Pediatr Oncol; 1978 May 16; 4(2):133-9. PubMed ID: 78437
    [Abstract] [Full Text] [Related]

  • 13. High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
    Hall TC, Choi OS, Abadi A, Krant MJ.
    Ann Intern Med; 1967 Jun 16; 66(6):1144-53. PubMed ID: 5338940
    [No Abstract] [Full Text] [Related]

  • 14. Recent advances in chemotherapy of lymphoma.
    Lenhard RE, Owens AH.
    Johns Hopkins Med J; 1967 Aug 16; 121(2):136-40. PubMed ID: 5340335
    [No Abstract] [Full Text] [Related]

  • 15. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B, Krakoff I, Burchenal J, Karnofsky D, Golbey R, Dowling M, Oettgen H, Lipton A.
    Cancer; 1970 Feb 16; 25(2):279-305. PubMed ID: 4905154
    [No Abstract] [Full Text] [Related]

  • 16. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
    Mathé G, Schwarzenberg L, Pouillart P, Oldham R, Weiner R, Jasmin C, Rosenfeld C, Hayat M, Misset JL, Musset M, Schneider M, Amiel JL, De Vassal F.
    Cancer; 1974 Oct 16; 34(4):985-92. PubMed ID: 4608026
    [No Abstract] [Full Text] [Related]

  • 17. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G, Misset JL, de Vassal F, Hayat M, Gouveia J, Machover D, Belpomme D, Schwarzenberg L, Ribaud P, Pico JL, Musset M, Jasmin C, de Luca L.
    Nouv Presse Med; 1978 Feb 18; 7(7):525-8. PubMed ID: 273888
    [Abstract] [Full Text] [Related]

  • 18. Treatment of malignant lymphomas with methyl ester of streptonigrin (NSC 45384).
    Rivers SL, Whittington RM, Medrek TJ.
    Cancer; 1966 Oct 18; 19(10):1377-85. PubMed ID: 5337271
    [No Abstract] [Full Text] [Related]

  • 19. Leukemia and lymphoma.
    White LP.
    Geriatrics; 1970 Dec 18; 25(12):82-6. PubMed ID: 5274229
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
    Geib KR, Papazian R.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977 Dec 18; 29(4):343-9. PubMed ID: 22916
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.